ATE358136T1 - Prionen-bindende peptidsequenzen - Google Patents
Prionen-bindende peptidsequenzenInfo
- Publication number
- ATE358136T1 ATE358136T1 AT02779505T AT02779505T ATE358136T1 AT E358136 T1 ATE358136 T1 AT E358136T1 AT 02779505 T AT02779505 T AT 02779505T AT 02779505 T AT02779505 T AT 02779505T AT E358136 T1 ATE358136 T1 AT E358136T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide sequences
- binding peptide
- prion binding
- prp
- prion protein
- Prior art date
Links
- 102000029797 Prion Human genes 0.000 title abstract 3
- 108091000054 Prion Proteins 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2002/011868 WO2004037854A1 (en) | 2002-10-23 | 2002-10-23 | Prion protein-binding peptide sequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE358136T1 true ATE358136T1 (de) | 2007-04-15 |
Family
ID=32116206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02779505T ATE358136T1 (de) | 2002-10-23 | 2002-10-23 | Prionen-bindende peptidsequenzen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1554305B1 (de) |
| AT (1) | ATE358136T1 (de) |
| AU (1) | AU2002342850A1 (de) |
| DE (1) | DE60219215T2 (de) |
| DK (1) | DK1554305T3 (de) |
| ES (1) | ES2283608T3 (de) |
| PT (1) | PT1554305E (de) |
| WO (1) | WO2004037854A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2398394T3 (es) | 2003-08-13 | 2013-03-15 | Novartis Vaccines And Diagnostics, Inc. | Reactivos peptídicos específicos de prión |
| WO2007030804A1 (en) | 2005-09-09 | 2007-03-15 | Novartis Ag | Prion-specific peptoid reagents |
| JP6047270B2 (ja) | 2006-08-11 | 2016-12-21 | バイオマリン テクノロジーズ ベー．フェー． | Ｄｎａリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段 |
| WO2009008727A2 (en) | 2007-07-12 | 2009-01-15 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs or tissues |
| NZ584793A (en) | 2007-10-26 | 2012-05-25 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
| USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
| EP2119783A1 (de) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Verfahren für effizientes Exon (44)-Skipping bei Duchenne-Muskeldystrophie und entsprechende Mittel |
| CN102459595A (zh) | 2009-04-24 | 2012-05-16 | 普罗森那技术公司 | 用于治疗dmd的包含肌苷的寡核苷酸 |
| CA2862628C (en) | 2012-01-27 | 2021-08-24 | Prosensa Technologies B.V. | Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002514224A (ja) * | 1997-06-02 | 2002-05-14 | ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア | プリオン蛋白質調節因子（ｐｐｍｆ）およびプリオン抵抗性動物 |
| GB9823835D0 (en) * | 1998-10-30 | 1998-12-23 | Univ London | Component for vaccine |
| US6399575B1 (en) * | 1998-11-10 | 2002-06-04 | Auburn University | Methods and compositions for targeting compounds to the central nervous system |
| AU5627000A (en) * | 1999-06-21 | 2001-02-05 | Inkine Pharmaceutical Company, Inc. | Angiocidin: a CYS-SER-VAL-THR-CYS-GLY specific tumor cell adhesion receptor |
| AU2002236499A1 (en) * | 2000-11-30 | 2002-06-11 | Uab Research Foundation | Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| EP1379283B1 (de) * | 2000-12-19 | 2008-02-13 | Palatin Technologies, Inc. | Identifizierung zielgerichteter faltungsstellen in peptiden und proteinen |
-
2002
- 2002-10-23 ES ES02779505T patent/ES2283608T3/es not_active Expired - Lifetime
- 2002-10-23 DE DE60219215T patent/DE60219215T2/de not_active Expired - Fee Related
- 2002-10-23 PT PT02779505T patent/PT1554305E/pt unknown
- 2002-10-23 AT AT02779505T patent/ATE358136T1/de not_active IP Right Cessation
- 2002-10-23 DK DK02779505T patent/DK1554305T3/da active
- 2002-10-23 EP EP02779505A patent/EP1554305B1/de not_active Expired - Lifetime
- 2002-10-23 AU AU2002342850A patent/AU2002342850A1/en not_active Abandoned
- 2002-10-23 WO PCT/EP2002/011868 patent/WO2004037854A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DK1554305T3 (da) | 2007-04-23 |
| WO2004037854A1 (en) | 2004-05-06 |
| AU2002342850A1 (en) | 2004-05-13 |
| ES2283608T3 (es) | 2007-11-01 |
| EP1554305A1 (de) | 2005-07-20 |
| EP1554305B1 (de) | 2007-03-28 |
| DE60219215D1 (de) | 2007-05-10 |
| DE60219215T2 (de) | 2008-01-03 |
| PT1554305E (pt) | 2007-05-31 |
| AU2002342850A8 (en) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124802T1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
| GB2433936A (en) | Therapeutic peptides comprising sequences derived from CDR2 or CDR3 of trem-1 and uses thereof to inhibit sepsis | |
| DE602004006433D1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| MA32982B1 (fr) | Proteines de liaison au recepteur cgrp humain | |
| IL232501A (en) | Peptide or polypeptide-resistant protein analogs and their uses | |
| HRP20070196T3 (hr) | Postupak za pročišćavanje il-18 vezivnog proteina | |
| WO2006023844A3 (en) | Compositions and methods comprising proteinase activated receptor antagonists | |
| BRPI0517973A (pt) | método para purificar o fsh | |
| NO20083050L (no) | Forbindelser og fremgangsmater for hemming av interaksjon av Bcl-proteiner med bindingspartnere | |
| NO20063064L (no) | Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte | |
| CY1112673T1 (el) | Φαινοξυ αιθερες αμινοξεων | |
| WO2004002418A3 (en) | Compositions and methods comprising protein activated receptor antagonists | |
| NO20053111L (no) | Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering. | |
| DK1554305T3 (da) | Prionprotein-bindende peptidsekvenser | |
| DE50013435D1 (de) | Peptide gegen dcm hervorrufende autoantikörper | |
| TW200724140A (en) | Hydantoin compounds | |
| DE60207043D1 (de) | Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese | |
| MX2008000230A (es) | Proteinas de enlace il-6. | |
| EA200600023A1 (ru) | НОВЫЕ БЕНЗАМИДЫ В КАЧЕСТВЕ PPARγ МОДУЛЯТОРОВ | |
| EA200801180A1 (ru) | Селективные пептидные агонисты рецептора vpac2 | |
| ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
| UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли | |
| ATE546154T1 (de) | Anti-angiogenetisches mittel und seine verwendung bei der krebsbehandlung | |
| EA200800342A1 (ru) | ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1554305 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |